Literature DB >> 9510201

Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1.

F Aoudjit1, E F Potworowski, Y St-Pierre.   

Abstract

The mechanisms that lead to the expression of matrix metalloproteinases (MMP) and tissue inhibitors of MMP (TIMPs) during the invasive process of normal and transformed T cells remain largely unknown. Since vascular cells form a dynamic tissue capable of responding to local stimuli and activating cells through the expression of cytokine receptors and specific cell adhesion molecules, we hypothesized that the firm adhesion of T lymphoma cells to endothelial cells is a critical event in the local production of MMP and TIMP. In the present work, we show that adhesion of lymphoma cells to endothelial cells induced a transient and reciprocal de novo expression of MMP-9 mRNA and enzymatic activity by both cell types. Up-regulation of MMP-9 in T lymphoma cells was concomitant to that of TIMP-1, and required direct contact with endothelial cells. Induction of MMP-9, but not of TIMP-1, was blocked by anti-LFA-1 and anti-intercellular adhesion molecule-1 Abs, indicating that induction of MMP-9 and TIMP-1 in lymphoma cells required direct, yet distinct, intercellular contact. In contrast, the induction of MMP-9 in endothelial cells by T lymphoma cells did not necessitate direct contact and could be achieved by exposure to IL-1 and TNF, or to the supernatant of T lymphoma cell culture. Together, these results demonstrate that firm adhesion of T lymphoma cells to endothelial cells participates in the production of MMP-9 in both cell types through bi-directional signaling pathways, and identify intercellular adhesion molecule-1/LFA-1 as a key interaction in the up-regulation of MMP-9 in T lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510201

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model.

Authors:  Katherine Biron-Pain; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2011-08-11       Impact factor: 9.261

2.  ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention.

Authors:  Nawar A Alkhamesi; Paul Ziprin; Katherine Pfistermuller; David H Peck; Ara W Darzi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme.

Authors:  Rachel L Manthe; Maximilian Loeck; Tridib Bhowmick; Melani Solomon; Silvia Muro
Journal:  J Control Release       Date:  2020-05-07       Impact factor: 9.776

4.  Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.

Authors:  M Kouwenhoven; C Carlström; V Ozenci; H Link
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

5.  Morphine and breast tumor metastasis: the role of matrix-degrading enzymes.

Authors:  Banafsheh Afsharimani; Joanne Baran; Satoshi Watanabe; Daniel Lindner; Peter J Cabot; Marie-Odile Parat
Journal:  Clin Exp Metastasis       Date:  2013-09-26       Impact factor: 5.150

6.  Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.

Authors:  Mineo Iwata; Manoj Pillai; Aravind Ramakrishnan; Robert C Hackman; H Joachim Deeg; Ghislain Opdenakker; Beverly Torok-Storb
Journal:  Blood       Date:  2007-01-01       Impact factor: 22.113

7.  Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1).

Authors:  A Ivanoff; J Ivanoff; K Hultenby; K G Sundqvist
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

8.  NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.

Authors:  M V P Nadella; W C Kisseberth; K S Nadella; N K Thudi; D H Thamm; E A McNiel; A Yilmaz; K Boris-Lawrie; T J Rosol
Journal:  Vet Comp Oncol       Date:  2008-03       Impact factor: 2.613

9.  Induction of Proteases in Peritoneal Carcinomatosis, the Role of ICAM-1/CD43 Interaction.

Authors:  Nawar A Alkhamesi; Gretta Roberts; Paul Ziprin; David H Peck
Journal:  Biomark Insights       Date:  2007-10-08

10.  Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1 signal.

Authors:  Dunyaporn Trachootham; Gang Chen; Wan Zhang; Weiqin Lu; Hui Zhang; Jinsong Liu; Peng Huang
Journal:  Free Radic Biol Med       Date:  2013-01-29       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.